Related Experiment Video

Updated: Aug 9, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Preventing the next event in the elderly: the PROSPER perspective

James Shepherd1

  • 1Department of Pathological Biochemistry, University Department of Pathological Biochemistry, Royal Infirmary, Glasgow, G4 0SF, Scotland, UK. jshepherd@gri-biochem.org.uk

Atherosclerosis. Supplements
|February 26, 2004
PubMed

Insights

Pravastatin statin therapy effectively reduced coronary heart disease risk in elderly individuals over three years. This study, PROSPER, confirms statin benefits for older adults, similar to middle-aged populations.

Area of Science:

  • Cardiovascular Medicine
  • Geriatric Medicine
  • Pharmacology

Background:

  • Statins are proven to reduce cardiovascular events in middle-aged individuals.
  • Efficacy and safety of statins in the elderly population remained unconfirmed.
  • Previous trials sub-analyzed elderly cohorts, but PROSPER specifically targeted this demographic.

Purpose of the Study:

  • To evaluate the benefits and risks of statin therapy (pravastatin) in elderly individuals.
  • To assess the impact of pravastatin on vascular risk in men and women aged 70 years and older.
  • To determine if statin therapy could be extended as a treatment strategy for the elderly.

Main Methods:

  • The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial.
  • Involved elderly men and women, evaluating pravastatin over three years.
  • Assessed outcomes including coronary heart disease, stroke, and transient ischemic attacks.

Main Results:

  • Pravastatin significantly reduced the risk of coronary heart disease in the elderly.
  • No significant reduction in stroke risk was observed, though a trend towards reducing transient ischemic attacks was noted.
  • Patients with the lowest baseline high-density lipoprotein cholesterol levels experienced the greatest benefit.
  • Drug interactions were not a significant clinical issue in this cohort.

Conclusions:

  • Pravastatin therapy is beneficial for reducing coronary heart disease risk in elderly individuals.
  • The findings support extending statin treatment strategies to the elderly population.
  • PROSPER provides evidence for the efficacy and safety of statins in older adults.

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...